Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Live-Dead Cell Staining Kit Workflow Guide
2026-08-08
Build a reproducible cell viability assay with Calcein-AM and Propidium Iodide for microscopy, flow cytometry, biomaterial screening, and drug cytotoxicity testing. This practical guide connects dual-fluorescence readouts with controls, quantitative gating, and troubleshooting for more defensible live/dead measurements.
-
GSK2606414: Translating PERK Biology into Strategy
2026-08-07
GSK2606414 offers translational researchers a selective way to test how PERK-dependent translational control connects ER stress with inflammation, pyroptosis, cancer biology, and disease-model phenotypes. This article interprets recent nucleus pulposus cell findings, outlines a validation workflow, and explains how to use pharmacology without overstating what current evidence proves.
-
Cepharanthine: Mechanistic Power and Translational Opportuni
2026-08-07
Cepharanthine, a biscoclaurine alkaloid, is redefining translational research strategies in apoptosis, endometriosis, and cancer therapy. This thought-leadership article synthesizes mechanistic insight, experimental best practices, and strategic guidance, empowering researchers to accelerate bench-to-bedside impact while highlighting the unique advantages and validated protocols of high-purity Cepharanthine from APExBIO.
-
ML216, BLM Helicase Inhibitor: Precision Workflows for DNA R
2026-08-06
ML216, a potent BLM helicase inhibitor from APExBIO, empowers researchers to dissect DNA repair mechanisms and exploit synthetic lethality in cancer models. This guide details advanced experimental setups, workflow optimizations, and troubleshooting strategies to maximize the impact of ML216 in both in vitro and in vivo applications.
-
E-4031: hERG Potassium Channel Blocker for 3D Cardiac Models
2026-08-06
E-4031 enables precise manipulation of cardiac electrophysiology in both 2D and 3D platforms, powering proarrhythmic substrate modeling and QT interval prolongation studies. Learn how cutting-edge workflows and advanced troubleshooting unlock its full potential in organoid-based research.
-
GI 254023X: Precision ADAM10 Inhibitor for Applied Research
2026-08-05
GI 254023X empowers researchers to dissect ADAM10-dependent pathways with nanomolar selectivity, enabling advanced studies in apoptosis, vascular integrity, and signaling. This guide delivers actionable workflows, troubleshooting insights, and comparative context—positioning GI 254023X from APExBIO as a cornerstone tool for translational bench research.
-
Harnessing Lambda Protein Phosphatase for Phosphorylation An
2026-08-05
Lambda Protein Phosphatase (RNase-free) from APExBIO sets the standard for precise dephosphorylation in protein phosphorylation studies. Its dual-specificity and high purity enable reliable antibody validation and functional analysis of dynamic signaling proteins like BMAL1.
-
SAR131675: VEGFR-3 Inhibitor Protocols for Fibrosis and Tumo
2026-08-04
SAR131675 enables high-specificity modulation of lymphangiogenic and angiogenic pathways, offering exceptional clarity in modeling hepatic fibrosis and tumor growth inhibition. This guide delivers actionable workflow enhancements, troubleshooting insights, and novel applications based on the latest preclinical data.
-
ML216, BLM Helicase Inhibitor: Dissecting Synthetic Lethalit
2026-08-04
Explore how ML216, a potent BLM helicase inhibitor, uniquely enables the mechanistic dissection of synthetic lethality in DNA repair and cancer research. This article reveals nuanced assay decisions and translational implications that set ML216 apart in the evolving landscape of DNA repair enzyme inhibitors.
-
Dual-Fluorescence Cell Viability: Bridging Bench to Bedside
2026-08-03
This thought-leadership article explores the mechanistic power and strategic value of Calcein-AM and Propidium Iodide-based dual fluorescence cell viability assays, with direct relevance for translational research. Drawing from recent advances in ocular drug delivery and antibacterial hydrogel technologies, we articulate how the Live-Dead Cell Staining Kit (SKU: K2081) from APExBIO empowers rigorous, reproducible, and clinically relevant data, ultimately fostering more robust workflows and accelerating therapeutic innovation. The article critically situates this dual-staining approach within the broader landscape of cell viability assessment, bridging experimental insight and translational application with actionable guidance.
-
Ferulic Acid Mitigates Chemotherapy-Induced POI via ER Stres
2026-08-03
This study demonstrates that ferulic acid (FA) alleviates chemotherapy-induced premature ovarian insufficiency (POI) by targeting the Grp78 and Perk-eIF2α-ATF4-CHOP pathway, thereby reducing endoplasmic reticulum (ER) stress and apoptosis in granulosa cells. The findings provide mechanistic evidence supporting FA as a potential therapeutic strategy for ovarian protection during chemotherapy.
-
HDAC Inhibition Reverses EBV-Induced Dedifferentiation in NP
2026-08-02
This study uncovers how EBV latent protein LMP1 drives dedifferentiation and stem-like cellular plasticity in nasopharyngeal carcinoma (NPC) by repressing CEBPA via STAT5A-mediated HDAC1/2 recruitment, and demonstrates that HDAC inhibition can restore differentiation. These findings highlight a novel epigenetic mechanism of virus-induced tumor plasticity and suggest HDAC inhibitors as promising differentiation therapies for solid tumors.
-
S-Adenosylmethionine in Methylation Reactions: Applied Proto
2026-08-01
S-Adenosylmethionine (SAM, ademetionine) is indispensable for precise, reproducible methylation reactions in DNA, RNA, and proteins, empowering CNS and neuropsychiatric research workflows. This article presents hands-on protocols, troubleshooting strategies, and experimental enhancements leveraging APExBIO’s high-purity SAM for methylation and central nervous system disorder studies.
-
AG-490 (Tyrphostin B42): Next-Gen Control of JAK2/STAT6 in H
2026-07-31
Explore AG-490 (Tyrphostin B42) as a precision tool for dissecting JAK2/STAT6-driven macrophage polarization and immunopathological modulation in hepatocellular carcinoma research. This article uniquely focuses on experimental design and practical assay optimization, integrating the latest evidence on exosomal SNORD52-mediated signaling.
-
Geneticin (G-418 Sulfate): Beyond Selection—Decoding Transla
2026-07-31
Explore how Geneticin (G418 Sulfate) enables precise genetic engineering and antiviral research through advanced ribosomal inhibition. This in-depth article reveals new insights into its translational control mechanisms and practical assay optimization.